0 NASDAQ Companies - January 3, 2019Kitov Signs Marketing and Distribution Agreement for its Lead Product Consensi™ in the U.S. with Coeptis Pharmaceuticals– Kitov to receive $3.5M milestone payments and 40% – 60% of net profit on sales of Consensi ™– Coeptis […]Read More
0 NASDAQ Companies - January 3, 2019Court sanction of the SchemeNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION […]Read More
0 NASDAQ Companies - January 3, 2019Valeritas Announces V-Go® is Preferred on Humana Part D FormulariesBRIDGEWATER, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) — Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of […]Read More
0 NASDAQ Companies - January 3, 2019Resonant Inc. Expands Relationship with its Largest Tier 1 CustomerReaffirms customer’s ongoing support of the power and flexibility of Resonant’s ISN design platform Four new designs licensed for modules […]Read More
0 NASDAQ Companies - January 3, 2019Helius Medical Technologies, Inc. Announces Fourth Partnership to Implement Clinical Experience Programs with PoNS™ Treatment in the United StatesNEWTOWN, Pa., Jan. 03, 2019 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]Read More
0 Canadian Stock Exchange News - January 3, 2019Veritas and South West Agromart Launch Agriculture Data Sales CollaborationTORONTO and CHATHAM, Ontario, Jan. 03, 2019 (GLOBE NEWSWIRE) — Deveron UAS Corp. (CSE: DVR) (“Deveron” or the “Company”) and […]Read More
0 NASDAQ Companies - January 3, 2019EyePoint Pharmaceuticals Provides 2019 Commercial Update– DEXYCUTM commercial launch now expected in 1Q19, earlier than prior guidance of 1H19 – – YUTIQTM commercial launch on […]Read More
0 NASDAQ Companies - January 3, 2019ProQR to Host R&D Day in New York on January 29LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR) will host a Research & […]Read More
0 NASDAQ Companies - January 3, 2019Chongqing Jingdong Pharmaceutical and Athenex Announce a Strategic Partnership and Licensing Agreement to Develop and Commercialize KX2-391 in ChinaChongqing Jingdong Pharmaceutical strengthens its product portfolio of innovative drugs with novel small molecule KX2-391 Athenex further builds its presence […]Read More
0 NASDAQ Companies - January 3, 2019Sandy Spring Bancorp, Inc. to Webcast Fourth Quarter Earnings Conference Call on January 17, 2019OLNEY, Md., Jan. 03, 2019 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc. (Nasdaq: SASR) will announce its fourth quarter earnings […]Read More